NIOSOMES: CLASSIFICATION, PREPARATION AND APPLICATION

Kamlesh Maurya; Arpita Singh; Swarnima Pandey; Nitish Kumar; Mohd. Aqil Siddhiqui

doi:10.46956/ijihd.vi.120

Kamlesh Maurya Master of Pharmacy
Arpita Singh GOEL Institute of Pharmacy & Sciences, Faizabad Road, Beside Indira Canal, Lucknow, 226028, India
Swarnima Pandey Goel Institute of Pharmacy and Sciences, Lucknow, 226028, UP, India
Nitish Kumar Goel Institute of Pharmacy and Sciences, Lucknow, 226028, UP, India
Mohd. Aqil Siddhiqui Goel Institute of Pharmacy and Sciences, Lucknow, 226028, UP, India

DOI https://doi.org/10.46956/ijihd.vi.120

Abstract

Vesicular medication delivery system, for instance, niosomes may be a novel medication delivery system, during which the answer is enclosed in vesicle which is formed by Non-ionic surfactant. Structurally, niosomes are almost like liposomes, therein they're also made from a bilayer. However, the bilayer within the case of niosomes is formed from non-ionic surface actives agents instead of phospholipids as seen just in case of liposomes. Niosomes tackled the difficulty of insolubility, instability, low bioavailability and fast debasement of medicines. The vesicular system of niosomes, with their bilayer structure assembled by nonionic surfactants, is in a position to reinforce the bioavailability of a drug to a predetermined area for a period. The both hydrophilic or lipophilic nature (amphiphilic nature) of niosomes increase their capacity in encapsulating lipophilic or hydrophilic drugs. Differents type additives, such as cholesterol, are often wont to maintain the rigidity of the niosomes structure. The basic aspects of niosomes, such as their structural components, methods of preparation, and current applications to various diseases.

Keywords: Niosomes, method of preparation, limitations, application

Downloads

Download data is not yet available.

References

1) Allen TM. Liposomal drug formulations: rationale for development and what we can expect for the future. Drugs. 1998; 56:747–56
2) Chen X, Huang W, Wong BC, Yin L, Wong YF, Xu M, et al. Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery. Int J Nanomedicine. 2012; 7:1139–48.
3) Shek PN, Suntres ZE, Brooks JI, Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery. J Drug Target. 1994; 2:431–42.
4) Parthasarathi G, Udupa N, Umadevi P, Pillai G. Niosome encapsulated of vincristine sulfate: improved anticancer activity with reduced toxicity in mice. J Drug Target. 1994; 2:173–82.
5) Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, et al. Formulation and in vitro evaluation of ciprofloxacin containing niosome for pulmonary delivery. J Microencapsul. 2010; 27:618–27.
6) Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes—non-ionic surfactant vesicles. J Pharm Pharmacol. 1985; 37:863–68
7) Punithavalli G, Vignesh M. Formulation of Niosomal Suspension with enhanced oral bioavailability of Diclofenac sodium. Journal of Global Trends in Pharmaceutical Sciences. 2012; 3: 656-67
8) Makeshwar K, Wasankar S. Niosomes: a novel drug delivery system. Asian J. Pharm. Res. 2013; 3: 16-20
9) Sankhyan A, Pawar P. Recent Trends in Niosome as Vesicular Drug Delivery System. Journal of Applied Pharmaceutical Science. 2012; 2: 20-32.
10) Gurjar P. Niosome: A Promising Pharmaceutical Drug Delivery. Int. J. Pharm Anal. 2014; 2: 425-431
11) Bagheri A, Chu B, Yaakob H. Niosomal Drug Delivery Systems: Formulation, Preparation and Applications. World Applied Sciences Journal. 2014; 32: 1671-1685.
12) Madhav N, Saini A. Niosomes: A novel drug delivery system. International journal of research in pharmacy and chemistry. 2011; 1: 498-511
13) Chandraprakash KS, Udupa N, Umadevi P and Pillai GK, Indian J. Pharm. Sci., 54, 1992, pp. 197.
14) www.pharmainfo.net/reviews/niosome-unique-drug delivery system
15) Duijad RC, Manvi FC, Swati S and Rony M, Indian Drugs, 2008, pp. 713
16) Verma A. A vital role of niosomes on Controlled and Novel Drug delivery. Indian Journal of Novel Drug Delivery. 2011; 3: 238-246.
17) Arul J. An Overview on Niosome as Carrier in Dermal Drug Delivery. J. Pharm. Sci. & Research. 2015; 7: 923-929.
18) Vyas S, Khar R. Targeted and Controlled Drug Delivery, Novel Carrier System. CBS publication. 2007; 1: 249-279
19) Bagheri A, Chu B, Yaakob H. Niosomal Drug Delivery Systems: Formulation Preparation and Applications. World Applied Sciences Journal. 2014; 32: 1671-1685.7.
20) Goswami S, Pathak D. Niosomes, A review of current status and application, World Journal of Pharmacy and Pharmaceutical Sciences. 2017; 6: 594-615.21.
21) Gayatri D, Venkatesh P, Udupa N. Niosomal sumatriptan succinate for nasal administration. Int. J. Pharm. Sci. 2000; 62: 479-481.
22) Hu C, Rhodes D. Proniosomes: A novel drug carrier preparation. Int J.Pharm. 1999; 185: 23-35.
23) Silver BL. The physical chemistry of membranes. New York: Alan/Unwin and Solomon Press. 1985; 209-230.
24) Khandare J, Madhavi G, Tamhankar B. Niosomes novel drug delivery system. The East Pharmacist. 1994; 37: 61-64.
25) Maver L, Bally M, Hope M, Cullis P. Biochem. Biophys. Acta. 1985; 816: 294-302.
26) Blazek-Walsh A, Rhodes D. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharm. Res. 2001; 18: 656-661.
27) Baillie A, Florence A, Hume L, Muirhead G, Rogerson A. The preparation and properties of niosomes non-ionic surfactant vesicles. J. Pharm. Pharmacol. 1985; 37: 863-868.
28) Debnath A, Kumar A. Structural and Functional significance of Niosome and Proniosome in Drug Delivery System. International Journal of Pharmacy and Engineering. 2015; 3: 621-637.
29) Alsarra A., Bosela A, Ahmed S.M, Mahrous G.M., Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. And Biopharm. 2004; 2(1): 1-6
30) Weissman G, Bloomgarden D, Kaplan R, Cohen C, Hoffstein S, Collins T, et al. A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells. Proc Natl Acad Sci 1975;72: 88-92.